PLX logo

Protalix BioTherapeutics (PLX) EV/EBITDA

EV/EBITDA

-23.43
+0.28+1.18%

7 min ago


Summary


Performance

PLX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherPLXvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

PLX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+1.2%-1.2%-1.1%
1 m1 month+8.2%-8.2%-7.3%
3 m3 months-42.8%+42.7%+35.5%
6 m6 months-295.8%+115.4%+156.0%
ytdytd-30.0%+30.0%+25.3%
1 y1 year-376.0%+38.0%+60.2%
5 y5 years-112.6%+58.3%-33.7%

PLX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-8.7%-27.35+14.3%
3 m3-month-15.07-55.5%-27.35+14.3%
6 m6-month-5.86-299.8%-27.35+14.3%
1 y1-year9.73-340.8%-27.35+14.3%
3 y3-year10.80-316.9%-27.35+14.3%
5 y5-year127.48-118.4%-83.92+72.1%
alltimeall time127.48-118.4%-489.09+95.2%

Protalix BioTherapeutics EV/EBITDA History

DateValue
2025
-23.43(+30.0%)
2024
-18.02(-266.9%)
2023
10.80(-229.3%)
2022
-8.35(+385.5%)
2021
-1.72(-104.4%)
2020
38.73(-466.8%)
2019
-10.56(+222.0%)
2018
-3.28(+144.8%)
2017
-1.34(-53.1%)
2016
-2.86(-38.0%)
2015
-4.61(-37.4%)
2014
-7.37(-35.5%)
2013
-11.43(-79.2%)
DateValue
2012
-54.89(+282.2%)
2011
-14.36(-51.0%)
2010
-29.31(+93.6%)
2009
-15.14(+256.2%)
2008
-4.25(-25.3%)
2007
-5.69(-93.9%)
2006
-93.19(+2593.4%)
2005
-3.46(>+9900.0%)
2004
-0.01(-99.9%)
2003
-6.70(-328.7%)
2002
2.93(+365.1%)
2001
0.63(-169.2%)
2000
-0.91(-82.1%)
1999
-5.09

FAQ

  • What is Protalix BioTherapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Protalix BioTherapeutics?
  • What is PLX EV/EBITDA year-to-date change?
  • What is Protalix BioTherapeutics EV/EBITDA year-on-year change?

What is Protalix BioTherapeutics EV/EBITDA?

The current EV/EBITDA of PLX is -23.43

What is the all time high EV/EBITDA for Protalix BioTherapeutics?

Protalix BioTherapeutics all-time high EV/EBITDA is 127.48

What is PLX EV/EBITDA year-to-date change?

Protalix BioTherapeutics EV/EBITDA has changed by -5.41 (-30.02%) since the beginning of the year

What is Protalix BioTherapeutics EV/EBITDA year-on-year change?

Over the past year, PLX EV/EBITDA has changed by -31.92 (-375.97%)